Biotech | September 07, 2022
Lonza and Touchlight collaborate on end-to-end mRNA offering
Under the terms of the agreement, Lonza can now provide its customers with seamless access to Touchlight’s enzymatic DNA technology
Under the terms of the agreement, Lonza can now provide its customers with seamless access to Touchlight’s enzymatic DNA technology
The existing hospital premises has the scope to further scale up the bed capacity as and when required in the future with minimal Capex.
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
Govt committed to supporting pharma companies with industry-friendly policies
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Following the successful completion of the 7day BVLOS trials, Skye Air targets to undertake approximately 80 flights, each carrying blood samples and medicines for Aster Clinics
Deucravacitinib is currently under regulatory review in multiple regions, including the U.S., Europe and Japan, and would be the first selective allosteric tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of any disease
Subscribe To Our Newsletter & Stay Updated
